Zoetis Inc. (0M3Q.L)

USD 169.5

(-0.56%)

Total Debt Summary of Zoetis Inc.

  • Zoetis Inc.'s latest annual total debt in 2023 was 6.8 Billion USD , down -15.91% from previous year.
  • Zoetis Inc.'s latest quarterly total debt in 2024 Q2 was 6.74 Billion USD , down -0.38% from previous quarter.
  • Zoetis Inc. reported annual total debt of 8.09 Billion USD in 2022, up 19.98% from previous year.
  • Zoetis Inc. reported annual total debt of 6.74 Billion USD in 2021, down -8.41% from previous year.
  • Zoetis Inc. reported quarterly total debt of 6.74 Billion USD for 2024 Q2, down -0.38% from previous quarter.
  • Zoetis Inc. reported quarterly total debt of 6.77 Billion USD for 2024 Q1, down -0.49% from previous quarter.

Annual Total Debt Chart of Zoetis Inc. (2023 - 2010)

Historical Annual Total Debt of Zoetis Inc. (2023 - 2010)

Year Total Debt Total Debt Growth
2023 6.8 Billion USD -15.91%
2022 8.09 Billion USD 19.98%
2021 6.74 Billion USD -8.41%
2020 7.36 Billion USD 11.36%
2019 6.61 Billion USD 2.46%
2018 6.45 Billion USD 30.26%
2017 4.95 Billion USD 10.85%
2016 4.46 Billion USD -8.22%
2015 4.86 Billion USD 33.37%
2014 3.65 Billion USD -0.19%
2013 3.65 Billion USD 528.35%
2012 582 Million USD 1.22%
2011 575 Million USD -19.13%
2010 711 Million USD 0.0%

Peer Total Debt Comparison of Zoetis Inc.

Name Total Debt Total Debt Difference
Editas Medicine, Inc. 36.53 Million USD -18519.991%
Dynavax Technologies Corporation 256.91 Million USD -2547.968%
Supernus Pharmaceuticals, Inc. 41.52 Million USD -16282.113%
Perrigo Company plc 4.07 Billion USD -67.01%
Illumina, Inc. 2.26 Billion USD -200.752%
Thermo Fisher Scientific Inc. 34.91 Billion USD 80.517%
Iovance Biotherapeutics, Inc. 1 Million USD -680200.0%
Walgreens Boots Alliance, Inc. 9.55 Billion USD 28.794%
IQVIA Holdings Inc. 14.23 Billion USD 52.196%
Heron Therapeutics, Inc. 173.75 Million USD -3815.328%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD -151.693%
Unity Biotechnology, Inc. 26.99 Million USD -25105.632%
Waters Corporation 2.35 Billion USD -188.812%
Biogen Inc. 7.33 Billion USD 7.293%
Sangamo Therapeutics, Inc. 38.1 Million USD -17753.769%
Evolus, Inc. 126.54 Million USD -5275.911%
Adicet Bio, Inc. 17.7 Million USD -38328.515%
Cara Therapeutics, Inc. 43.16 Million USD -15659.724%
bluebird bio, Inc. 330.32 Million USD -1959.481%
Esperion Therapeutics, Inc. 540.94 Million USD -1157.609%
FibroGen, Inc. 170.45 Million USD -3891.083%
Agilent Technologies, Inc. 2.73 Billion USD -148.739%
Corbus Pharmaceuticals Holdings, Inc. 20.88 Million USD -32474.815%
Homology Medicines, Inc. 44.05 Million USD -15342.412%
Geron Corporation 85.89 Million USD -7819.766%
Alnylam Pharmaceuticals, Inc. 2.39 Billion USD -183.693%
Amicus Therapeutics, Inc. 445.05 Million USD -1428.561%
Myriad Genetics, Inc. 145 Million USD -4591.724%
Viking Therapeutics, Inc. 1.26 Million USD -539820.635%
Intellia Therapeutics, Inc. 115.34 Million USD -5797.907%
Abeona Therapeutics Inc. 4.4 Million USD -154443.389%
Mettler-Toledo International Inc. 2.16 Billion USD -213.825%
BioMarin Pharmaceutical Inc. 1.13 Billion USD -499.978%
Vertex Pharmaceuticals Incorporated 808.4 Million USD -741.539%
Kala Pharmaceuticals, Inc. 36.32 Million USD -18629.18%
Ionis Pharmaceuticals, Inc. 1.45 Billion USD -368.03%
Atara Biotherapeutics, Inc. 57.87 Million USD -11655.253%
Verastem, Inc. 41.55 Million USD -16270.287%
Nektar Therapeutics 230.4 Million USD -2852.678%
Axsome Therapeutics, Inc. 186.37 Million USD -3550.226%
Aclaris Therapeutics, Inc. 3.07 Million USD -221207.742%
Sarepta Therapeutics, Inc. 1.39 Billion USD -387.039%
OPKO Health, Inc. 326.56 Million USD -1983.206%
Exelixis, Inc. 189.94 Million USD -3481.582%
Neurocrine Biosciences, Inc. 428.4 Million USD -1488.002%
Corcept Therapeutics Incorporated 151 Thousand USD -4505198.013%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 138.4 Million USD -4815.143%
Imunon, Inc. 1.13 Million USD -597024.708%
Blueprint Medicines Corporation 774.12 Million USD -778.802%
Insmed Incorporated 1.2 Billion USD -465.036%
Halozyme Therapeutics, Inc. 1.49 Billion USD -353.761%
Agios Pharmaceuticals, Inc. 56.98 Million USD -11837.601%
TG Therapeutics, Inc. 110.79 Million USD -6040.169%
Incyte Corporation 38.28 Million USD -17668.433%
Emergent BioSolutions Inc. 877.5 Million USD -675.271%